Trials / Unknown
UnknownNCT02961634
Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Single-center study, single blind, comparative with the objective of evaluating the efficacy and safety of an investigational product as an adjunct in the treatment of onychomycosis improvement of 90 days ± 2 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nailner 2 in 1 | Nailner 2 in 1 is a combination of assets that alter the pH of the nail and is used as an adjunct in the treatment of onychomycosis. |
| DRUG | Ciclopirox 8% | Ciclopirox 8% is a glaze used in the treatment of onychomycosis |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2016-11-11
- Last updated
- 2017-03-31
Source: ClinicalTrials.gov record NCT02961634. Inclusion in this directory is not an endorsement.